Please assess the completion status of the following clinical trial:

Trial Title: Budesonide / Formoterol in Treatment of Exacerbations of COPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* smoking-induced COPD according to ATS criteria~* FEV1 \<85% of predicted at enrolment and \<70% of predicted but \> 0.7 Liter at Exacerbation~* FEV1/IVC ratio \<88% of predicted for men and \<89% for women~Exclusion Criteria:~* history of asthma~* known hypersensitivity to the study drugs~* serious concomitant diseases~* pregnancy or lactating~* abnormal Chest X-ray or blood gasses

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).